Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital

Conditions

• Cancer of the Lung
• Lung Cancer

Eligibility Criteria

Sex

ALL

Age

20 Years - N/A

Healthy Volunteers

Accepted

Interventions

• Pink and Pearl Campaign — OTHER
  This campaign leverages established infrastructure such as nurse navigation and referral to screening or primary care for further shared decision-making on cancer screening.

Study Details

Inspired by the ongoing Pink \& Pearl Campaign, the breast radiology service of Christian Hospital in north St. Louis County will partner with Siteman Cancer Center to pilot this campaign in its mammography clinics in order to promote awareness, referral, and completion of lung cancer screening (LCS) among eligible women. This campaign leverages established infrastructure such as nurse navigation and referral to screening or primary care for further shared decision-making on cancer screening. The purpose of this study is to evaluate the effectiveness of the Pink \& Pearl Campaign in improving LCS uptake among LCS-eligible women undergoing mammography at Christian Hospital. This evaluation is grounded in the Integrated Screening Action Model that depicts individual- and environmental-level influences on the screening behavior process. Using an explanatory sequential mixed methods design, which combines both quantitative and qualitative approaches, our specific aims for this proposal are to: a) assess whether the Pink \& Pearl Campaign increases referrals and uptake/completion of LCS among LCS-eligible women undergoing screening mammography; b) determine median time-to-screening after referral to LCS; and c) evaluate individual and health system factors influencing LCS uptake and implementation outcomes of the campaign. These implementation outcomes will help identify whether the campaign was put in place successfully or not. This proposal will inform strategies for integrating cancer screening programs to improve poorly performing programs like LCS.

Key Dates

Start date

Feb 23, 2026

Status verified

Feb 2026

Primary completion

Aug 31, 2026

Completion

Aug 31, 2026

Study Design

Enrollment

5,515 participants (estimated)

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SCREENING

Arms

• Experimental: Participants - scheduled for mammography and eligible for LCS
  All women coming in for breast cancer screening will be assessed for LCS eligibility using a screening questionnaire administered by mammography technicians. Patients who are determined to be eligible for LCS will be asked by the mammography technician if they will opt into being contacted by the nurse navigator, who will facilitate their referral to primary care to schedule a LCS appointment at Siteman Cancer Center.
• No Intervention: Providers
  Providers in the breast radiology service who referred women to LCS. Investigators will gather information on the feasibility, acceptability, and appropriateness of the Pink and Pearl project.

Primary Outcome Measure

Proportion of women referred from the breast radiology service who successfully complete LCS 6-months post-Pink & Pearl implementation [ Time Frame: At 6 months ]

Central Contacts

• Beryne Odeny, M.D., MPH, Ph.D.
  314-362-1183
  [email protected]
• Michelle V Lee, M.D.
  314-454-7405
  [email protected]

Locations (1)

Find similar trials in St Louis, MO

Related Studies

• Integrated Cancer Repository for Cancer Research
  Recruiting · University of Nebraska · Greenwood Village, Colorado
• Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
  Recruiting · Washington University School of Medicine · St Louis, Missouri
• A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
  PHASE2 · Not Yet Recruiting · Jun Zhang, MD, PhD · Kansas City, Kansas
• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
  PHASE1/PHASE2 · Recruiting · A2 Biotherapeutics Inc. · Gilbert, Arizona